A prospective study on longterm low dose spironolactone use in patients with NYHA class Ⅱ: a five ye

• 作 者: Jinling Wu Yuan Qian Du Yidan Wang Guobin Miao Jin Chen Lin Zhang Jiamei Liu yin Yue Zhiyong Zhang Juan Zhang Guiling Ma Ying Chen hongli Zhang Yuting
• 机 构: Chaoyang Hospital Affiliated to Capital Medical University,Beijing 100020,China
• 出 处: 第14届中国南方国际心血管病学术会议
• 发表日期: 2012年5期

Objectives Spironolactone,an aldosterone receptor blocker,has been shown to be beneficial in patients with chronic severe heart failure.We tested whether low dose spironolactone is safe and effective in patients with chronic heart failure and mild symptom over a five years period.